{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Enicostemma littorale", "biosynthesis", "inflammatory cytokines", "metabolic pathway", "molecular targets", "swertiamarin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34188450", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "07"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.2147/DDDT.S299753"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2021"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.", "Pagination": {"StartPage": "2721", "EndPage": "2746", "MedlinePgn": "2721-2746"}, "Abstract": {"AbstractText": ["Swertiamarin, a seco-iridoid glycoside, is mainly found in <i>Enicostemma littorale</i> Blume (<i>E. littorale</i>) and exhibits therapeutic activities for various diseases. The present study aimed to provide a review of swertiamarin in terms of its phytochemistry, physicochemical properties, biosynthesis, pharmacology and therapeutic potential. Relevant literature was collected from several scientific databases, including PubMed, ScienceDirect, Scopus and Google Scholar, between 1990 and the present. This review included the distribution of swertiamarin in medicinal plants and its isolation, characterization, physicochemical properties and possible biosynthetic pathways. A comprehensive summary of the pharmacological activities, therapeutic potential and metabolic pathways of swertiamarin was also included after careful screening and tabulation. Based on the reported evidence, swertiamarin meets all five of Lipinski's rules for drug-like properties. Thereafter, the physicochemical properties of swertiamarin were detailed and analyzed. A simple and rapid method for isolating swertiamarin from <i>E. littorale</i> has been described. The present review proposed that swertiamarin may be biosynthesized by the mevalonate or nonmevalonate pathways, followed by the seco-iridoid pathway. It has also been found that swertiamarin is a potent compound with diverse pharmacological activities, including hepatoprotective, analgesic, anti-inflammatory, antiarthritis, antidiabetic, antioxidant, neuroprotective and gastroprotective activities. The anticancer activity of swertiamarin against different cancer cell lines has been recently reported. The underlying mechanisms of all these pharmacological effects are diverse and seem to involve the regulation of different molecular targets, including growth factors, inflammatory cytokines, protein kinases, apoptosis-related proteins, receptors and enzymes. Swertiamarin also modulates the activity of several transcription factors, and their signaling pathways in various pathological conditions are also discussed. Moreover, we have highlighted the toxicity profile, pharmacokinetics and possible structural modifications of swertiamarin. The pharmacological activities and therapeutic potential of swertiamarin have been extensively investigated. However, more advanced studies are required including clinical trials and studies on the bioavailability, permeability and administration of safe doses to offer swertiamarin as a novel candidate for future drug development."], "CopyrightInformation": "\u00a9 2021 Muhamad Fadzil et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh, Perak, Malaysia."}], "LastName": "Muhamad Fadzil", "ForeName": "Nur Sakinah", "Initials": "NS"}, {"Identifier": ["0000-0002-3022-6137"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh, Perak, Malaysia."}], "LastName": "Sekar", "ForeName": "Mahendran", "Initials": "M"}, {"Identifier": ["0000-0001-6470-3651"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia."}], "LastName": "Gan", "ForeName": "Siew Hua", "Initials": "SH"}, {"Identifier": ["0000-0002-2888-2418"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Th\u00e9rapeutique, Sorbonne Universit\u00e9, Universit\u00e9 de Paris, Paris, France."}], "LastName": "Bonam", "ForeName": "Srinivasa Reddy", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, School of Medicine, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Bandar Saujana Putra, Selangor, Malaysia."}], "LastName": "Wu", "ForeName": "Yuan Seng", "Initials": "YS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru, Karnataka, India."}], "LastName": "Vaijanathappa", "ForeName": "Jaishree", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India."}], "LastName": "Ravi", "ForeName": "Subban", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh, Perak, Malaysia."}], "LastName": "Lum", "ForeName": "Pei Teng", "Initials": "PT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "D.S.T.S. Mandal's College of Pharmacy, Solapur, Maharashtra, India."}], "LastName": "Dhadde", "ForeName": "Shivsharan B", "Initials": "SB"}], "PublicationTypeList": ["Journal Article", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Iridoid Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrones"}, {"RegistryNumber": "4038595T7Y", "NameOfSubstance": "swertiamarin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Drug Development"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["chemistry"], "DescriptorName": "Gentianaceae"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Iridoid Glucosides"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Pyrones"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bonam SR, Wu YS, Tunki L, et al. What has come out from phytomedicines and herbal edibles for the treatment of cancer? Chem Med Chem. 2018;13(18):1854\u20131872. doi:10.1002/cmdc.201800343", "ArticleIdList": ["10.1002/cmdc.201800343", "29927521"]}, {"Citation": "Ramakrishnan P, Loh WM, Gopinath SC, et al. Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer. Acta Pharm Sin B. 2020;10(3):399\u2013413. doi:10.1016/j.apsb.2019.11.008", "ArticleIdList": ["10.1016/j.apsb.2019.11.008", "PMC7049637", "32140388"]}, {"Citation": "Anwar MMA, Aftab K, Aftab K, Aftab K. Enicostema littorale: a new source of swertiamarin. Pak J Pharm Sci. 1996;9(1):29\u201335.", "ArticleIdList": ["16414773"]}, {"Citation": "Saranya R, Thirumalai T, Hemalatha M, et al. Pharmacognosy of Enicostemma littorale: a review. Asian Pac J Trop Biomed. 2013;3(1):79\u201384. doi:10.1016/S2221-1691(13)60028-3", "ArticleIdList": ["10.1016/S2221-1691(13)60028-3", "PMC3609395", "23570022"]}, {"Citation": "Jaishree V, Badami S. Antioxidant and hepatoprotective effect of swertiamarin from Enicostemma axillare against D-galactosamine induced acute liver damage in rats. J Ethnopharmacol. 2010;130(1):103\u2013106. doi:10.1016/j.jep.2010.04.019", "ArticleIdList": ["10.1016/j.jep.2010.04.019", "20420896"]}, {"Citation": "Maroo J, Vasu V, Gupta S. Dose dependent hypoglycemic effect of aqueous extract of Enicostemma littorale Blume in alloxan induced diabetic rats. Phytomedicine. 2003;10(2\u20133):196\u2013199. doi:10.1078/094471103321659933", "ArticleIdList": ["10.1078/094471103321659933", "12725576"]}, {"Citation": "Piatczak E, Krolicka A, Wysokinska H. Genetic transformation of Centaurium erythraea Rafn by Agrobacterium rhizogenes and the production of secoiridoids. Plant Cell Rep. 2006;25(12):1308\u20131315. doi:10.1007/s00299-006-0155-0", "ArticleIdList": ["10.1007/s00299-006-0155-0", "16841219"]}, {"Citation": "Abe N, Nakano Y, Shimogomi A, et al. A new flavonol triglycoside from Eustoma grandiflorum. Nat Prod Commun. 2016;11(7):963\u2013964.", "ArticleIdList": ["30452172"]}, {"Citation": "Jonville M-C, Capel M, Fr\u00e9d\u00e9rich M, et al. Fagraldehyde, a secoiridoid isolated from Fagraea fragrans. J Nat Prod. 2008;71(12):2038\u20132040. doi:10.1021/np800291d", "ArticleIdList": ["10.1021/np800291d", "19053508"]}, {"Citation": "Tan R, Hu J, Dong L, et al. Two new secoiridoid glycosides from Gentiana algida. Planta Med. 1997;63(06):567\u2013569. doi:10.1055/s-2006-957770", "ArticleIdList": ["10.1055/s-2006-957770", "17252380"]}, {"Citation": "Zhou L, Li X-K, Miao F, et al. Further studies on the chemical constituents of Chinese folk medicine Gentiana apiata NE Br. J Asian Nat Prod Res. 2009;11(4):345\u2013351. doi:10.1080/10286020902819814", "ArticleIdList": ["10.1080/10286020902819814", "19431015"]}, {"Citation": "Mihailovic V, Matic S, Mi\u0161ic D, et al. Chemical composition, antioxidant and antigenotoxic activities of different fractions of Gentiana asclepiadea L. roots extract. EXCLI J. 2013;12:807.", "ArticleIdList": ["PMC4662184", "26622219"]}, {"Citation": "Wanga Y, Ahmadc B, Duana B, et al. Chemical and genetic comparative analysis of Gentiana crassicaulis and Gentiana. Chem Biodivers. 2016;13:1\u20136. doi:10.1002/cbdv.201400363", "ArticleIdList": ["10.1002/cbdv.201400363", "27144464"]}, {"Citation": "Mihailovi\u0107 V, Katani\u0107 J, Mi\u0161i\u0107 D, et al. Hepatoprotective effects of secoiridoid-rich extracts from Gentiana cruciata L. against carbon tetrachloride induced liver damage in rats. Food Funct. 2014;5(8):1795\u20131803. doi:10.1039/C4FO00088A", "ArticleIdList": ["10.1039/C4FO00088A", "24912992"]}, {"Citation": "Wu X, Tang S, Jin Y, et al. New analytical method for the study of metabolism of swertiamarin in rats after oral administration by UPLC\u2010TOF\u2010MS following DNPH derivatization. Biomed Chromatogr. 2015;29(8):1184\u20131189. doi:10.1002/bmc.3406", "ArticleIdList": ["10.1002/bmc.3406", "25612327"]}, {"Citation": "Chueh F-S, Chen -C-C, Sagare AP, et al. Quantitative determination of secoiridoid glucosides in in vitro propagated plants of Gentiana davidii var. formosana by high performance liquid chromatography. Planta Med. 2001;67(1):70\u201373. doi:10.1055/s-2001-10622", "ArticleIdList": ["10.1055/s-2001-10622", "11270726"]}, {"Citation": "\u00c7ali\u015f \u0130, R\u00fcegger H, Chun Z, et al. Secoiridoid glucosides isolated from Gentiana gelida. Planta Med. 1990;56(4):406\u2013409. doi:10.1055/s-2006-960995", "ArticleIdList": ["10.1055/s-2006-960995", "17221438"]}, {"Citation": "Ghazanfar K, Mubashir K, Dar SA, et al. Gentiana kurroo Royle attenuates the metabolic aberrations in diabetic rats; Swertiamarin, swertisin and lupeol being the possible bioactive principles. J Complement Integr Med. 2017;14(3):3. doi:10.1515/jcim-2017-0002", "ArticleIdList": ["10.1515/jcim-2017-0002", "28731312"]}, {"Citation": "Zhang X, Zhang H, Ji L. Simultaneous determination of four constituents in wild Gentiana lawrencei from Qinghai province by RP-HPLC. China J Chinese Mat Med. 2009;34(22):2884\u20132886.", "ArticleIdList": ["20209951"]}, {"Citation": "Kesavan R, Potunuru UR, Nastasijevi\u0107 B, et al. Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts. PLoS One. 2013;8(4):e61393. doi:10.1371/journal.pone.0061393", "ArticleIdList": ["10.1371/journal.pone.0061393", "PMC3630200", "23637826"]}, {"Citation": "Zhang J, Tian Z, Lou Z. Simultaneous determination of five bitter secoiridoid glycosides in nine Chinese Gentiana species used as the Chinese drug \u201dlong dan\u201d by high performance liquid chromatography. Acta Pharm Sin. 1991;26(11):864\u2013870.", "ArticleIdList": ["1823982"]}, {"Citation": "Suyama Y, Kurimoto S-I, Kawazoe K, et al. Rigenolide A, a new secoiridoid glucoside with a cyclobutane skeleton, and three new acylated secoiridoid glucosides from Gentiana rigescens Franch. Fitoterapia. 2013;91:166\u2013172. doi:10.1016/j.fitote.2013.08.006", "ArticleIdList": ["10.1016/j.fitote.2013.08.006", "23994629"]}, {"Citation": "Kshirsagar PR, Pai SR, Nimbalkar MS, et al. RP-HPLC analysis of seco-iridoid glycoside swertiamarin from different Swertia species. Nat Prod Res. 2016;30(7):865\u2013868. doi:10.1080/14786419.2015.1071366", "ArticleIdList": ["10.1080/14786419.2015.1071366", "26299409"]}, {"Citation": "Luo Y, Nie R. Studies on iridoid glycosides from Swertia angustifolia. Acta Pharm Sin. 1992;27(2):125.", "ArticleIdList": ["1414367"]}, {"Citation": "Lad H, Bhatnagar D. Amelioration of oxidative and inflammatory changes by Swertia chirayita leaves in experimental arthritis. Inflammopharmacology. 2016;24(6):363\u2013375. doi:10.1007/s10787-016-0290-3", "ArticleIdList": ["10.1007/s10787-016-0290-3", "27738917"]}, {"Citation": "Mahendran G, Thamotharan G, Sengottuvelu S, et al. RETRACTED: anti-diabetic activity of Swertia corymbosa (Griseb.) Wight ex C.B. Clarke aerial parts extract in streptozotocin induced diabetic rats. J Ethnopharmacol. 2014;151(3):1175\u20131183. doi:10.1016/j.jep.2013.12.032", "ArticleIdList": ["10.1016/j.jep.2013.12.032", "24378350"]}, {"Citation": "Cao T-W, Geng C-A, Ma Y-B, et al. Chemical constituents of Swertia mussotii and their anti-hepatitis B virus activity. Fitoterapia. 2015;102:15\u201322. doi:10.1016/j.fitote.2015.01.020", "ArticleIdList": ["10.1016/j.fitote.2015.01.020", "25665940"]}, {"Citation": "Wang -S-S, Zhao W-J, Han X-W, et al. Two new iridoid glycosides from the Tibetan folk medicine Swertia franchetiana. Chem Pharm Bull. 2005;53(6):674\u2013676. doi:10.1248/cpb.53.674", "ArticleIdList": ["10.1248/cpb.53.674", "15930781"]}, {"Citation": "Jiang FQ, Zhang XM, Ma Y, et al. Chemical constituents of Swertia hispidicalyx. J Chinese Mat Med. 2011;36(16):2215\u20132218.", "ArticleIdList": ["22097333"]}, {"Citation": "Rai A, Nakamura M, Takahashi H, et al. High-throughput sequencing and de novo transcriptome assembly of Swertia japonica to identify genes involved in the biosynthesis of therapeutic metabolites. Plant Cell Rep. 2016;35(10):2091\u20132111. doi:10.1007/s00299-016-2021-z", "ArticleIdList": ["10.1007/s00299-016-2021-z", "27378356"]}, {"Citation": "He K, Cao TW, Wang HL, et al. Chemical constituents of Swertia kouitchensis Franch. China J Chinese Mat Med. 2015;40(19):3811\u20133817.", "ArticleIdList": ["26975107"]}, {"Citation": "Saeidnia S, Ara L, Hajimehdipoor H, et al. Chemical constituents of Swertia longifolia Boiss. with \u03b1-amylase inhibitory activity. Res Pharm Sci. 2016;11(1):23.", "ArticleIdList": ["PMC4794934", "27051429"]}, {"Citation": "Kikuzaki H, Kawasaki Y, Kitamura S, et al. Secoiridoid Glucosides from Swertia mileensis. Planta Med. 1996;62(01):35\u201338. doi:10.1055/s-2006-957792", "ArticleIdList": ["10.1055/s-2006-957792", "8720386"]}, {"Citation": "Tian C, Zhang T, Wang L, et al. The hepatoprotective effect and chemical constituents of total iridoids and xanthones extracted from Swertia mussotii Franch. J Ethnopharmacol. 2014;154(1):259\u2013266. doi:10.1016/j.jep.2014.04.018", "ArticleIdList": ["10.1016/j.jep.2014.04.018", "24746481"]}, {"Citation": "He K, Cao T, Wang H, et al. Chemical constituents of Swertia patens. China J Chinese Mat Med. 2015;40(20):4012.", "ArticleIdList": ["27062819"]}, {"Citation": "Huang W-Z, Xu C-H, Zhou D-C, et al. Determination of iridoids and triterpenes in herb of Swertia pseudochinesis by RP-HPLC. China J Chinese Mat Med. 2007;32(23):2494\u20132496.", "ArticleIdList": ["18330241"]}, {"Citation": "Tan P, Liu Y, Hou C. Swertiapunimarin from Swertia punicea Hemsl. Acta Pharm Sin. 1993;28(7):522\u2013525.", "ArticleIdList": ["8285054"]}, {"Citation": "Nwafor PA, Abia GO, Bankhede HK. Antipyretic and antimalarial activities of crude leaf extract and fractions of Enicostema littorale. Asian Pac J Trop Dis. 2012;2(6):442\u2013447. doi:10.1016/S2222-1808(12)60097-8", "ArticleIdList": ["10.1016/S2222-1808(12)60097-8"]}, {"Citation": "Takate S, Pokharkar R, Chopade V, et al. Hepatoprotective activity of the ethyl acetate extract of Launaea intybacea (jacq) beauv in paracetamol induced hepato-toxicity in albino rats. Int J Pharm Sci Rev Res. 2010;1(2):72\u201374."}, {"Citation": "Patel N, Tyagi RK, Tandel N, et al. The molecular targets of swertiamarin and its derivatives confer anti-diabetic and anti-hyperlipidemic effects. Curr Drug Targets. 2018;19(16):1958\u20131967. doi:10.2174/1389450119666180406113428", "ArticleIdList": ["10.2174/1389450119666180406113428", "29623834"]}, {"Citation": "Jaishree V, Badami S, Kumar MR, et al. Antinociceptive activity of swertiamarin isolated from Enicostemma axillare. Phytomedicine. 2009;16(2\u20133):227\u2013232. doi:10.1016/j.phymed.2008.09.010", "ArticleIdList": ["10.1016/j.phymed.2008.09.010", "19019644"]}, {"Citation": "Vishwakarma S, Rajani M, Bagul M, et al. A rapid method for the isolation of swertiamarin from Enicostemma littorale. Pharm Biol. 2004;42(6):400\u2013403. doi:10.1080/13880200490885095", "ArticleIdList": ["10.1080/13880200490885095"]}, {"Citation": "Kakarla RK, Rajendran M, Paulraj B, et al. Isolation and characterization of Swertiamarin from aerial parts of Enicostemma littorale Blume. Int J Bioassays. 2019;8(1):5712\u20135715."}, {"Citation": "Rana V. Separation and identification of swertiamarin from Enicostema axillare Lam. raynal by centrifugal partition chromatography and nuclear magnetic resonance-mass spectrometry. J Pharm Sci Emerg Drugs. 2014;1:2."}, {"Citation": "NIH. Swertiamarin. Vol. 2020. 2020."}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1\u20133):3\u201325. doi:10.1016/S0169-409X(96)00423-1", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Miettinen K, Dong L, Navrot N, et al. The seco-iridoid pathway from Catharanthus roseus. Nat Commun. 2014;5(1):1\u201312.", "ArticleIdList": ["PMC3992524", "24710322"]}, {"Citation": "Oudin A, Mahroug S, Courdavault V, et al. Spatial distribution and hormonal regulation of gene products from methyl erythritol phosphate and monoterpene-secoiridoid pathways in Catharanthus roseus. Plant Mol Biol. 2007;65(1\u20132):13\u201330. doi:10.1007/s11103-007-9190-7", "ArticleIdList": ["10.1007/s11103-007-9190-7", "17611800"]}, {"Citation": "Loyola-Vargas VM, Galaz-\u00e1valos RM, K\u00fa-Cauich R. Catharanthus biosynthetic enzymes: the road ahead. Phytochem Rev. 2007;6(2):307\u2013339. doi:10.1007/s11101-007-9064-2", "ArticleIdList": ["10.1007/s11101-007-9064-2"]}, {"Citation": "Collu G, Unver N, Peltenburg-Looman AM, et al. Geraniol 10-hydroxylase 1, a cytochrome P450 enzyme involved in terpenoid indole alkaloid biosynthesis. FEBS Lett. 2001;508(2):215\u2013220. doi:10.1016/S0014-5793(01)03045-9", "ArticleIdList": ["10.1016/S0014-5793(01)03045-9", "11718718"]}, {"Citation": "Irmler S, Schr\u00f6der G, St\u2010Pierre B, et al. Indole alkaloid biosynthesis in Catharanthus roseus: new enzyme activities and identification of cytochrome P450 CYP72A1 as secologanin synthase. Plant J. 2000;24(6):797\u2013804. doi:10.1046/j.1365-313x.2000.00922.x", "ArticleIdList": ["10.1046/j.1365-313x.2000.00922.x", "11135113"]}, {"Citation": "Murata J, Roepke J, Gordon H, et al. The leaf epidermome of Catharanthus roseus reveals its biochemical specialization. Plant Cell. 2008;20(3):524\u2013542. doi:10.1105/tpc.107.056630", "ArticleIdList": ["10.1105/tpc.107.056630", "PMC2329939", "18326827"]}, {"Citation": "Zhu X, Zeng X, Sun C, et al. Biosynthetic pathway of terpenoid indole alkaloids in Catharanthus roseus. Front Med. 2014;8(3):285\u2013293. doi:10.1007/s11684-014-0350-2", "ArticleIdList": ["10.1007/s11684-014-0350-2", "25159992"]}, {"Citation": "Zhang M, Ma X, Xu H, et al. A natural AKT inhibitor swertiamarin targets AKT\u2010PH domain, inhibits downstream signaling, and alleviates inflammation. FEBS J. 2020;287(9):1816\u20131829. doi:10.1111/febs.15112", "ArticleIdList": ["10.1111/febs.15112", "31665825"]}, {"Citation": "Saravanan S, Islam VH, Babu NP, et al. Swertiamarin attenuates inflammation mediators via modulating NF-\u03baB/I \u03baB and JAK2/STAT3 transcription factors in adjuvant induced arthritis. Eur J Pharm Sci. 2014;56:70\u201386. doi:10.1016/j.ejps.2014.02.005", "ArticleIdList": ["10.1016/j.ejps.2014.02.005", "24582615"]}, {"Citation": "Saravanan S, Islam VH, Thirugnanasambantham K, et al. Swertiamarin ameliorates inflammation and osteoclastogenesis intermediates in IL-1\u03b2 induced rat fibroblast-like synoviocytes. Inflamm Res. 2014;63(6):451\u2013462. doi:10.1007/s00011-014-0717-5", "ArticleIdList": ["10.1007/s00011-014-0717-5", "24492951"]}, {"Citation": "Saravanan S, Pandikumar P, Babu NP, et al. In vivo and in vitro immunomodulatory potential of swertiamarin isolated from Enicostema axillare (Lam.) A. Raynal that acts as an anti-inflammatory agent. Inflammation. 2014;37(5):1374\u20131388. doi:10.1007/s10753-014-9862-9", "ArticleIdList": ["10.1007/s10753-014-9862-9", "24736879"]}, {"Citation": "Hairul-Islam M, Saravanan S, Thirugnanasambantham K, et al. Swertiamarin, a natural steroid, prevent bone erosion by modulating RANKL/RANK/OPG signaling. Int Immunopharmacol. 2017;53:114\u2013124. doi:10.1016/j.intimp.2017.10.022", "ArticleIdList": ["10.1016/j.intimp.2017.10.022", "29078090"]}, {"Citation": "Vaijanathappa J, Badami S. Antiedematogenic and free radical scavenging activity of swertiamarin isolated from Enicostemma axillare. Planta Med. 2009;75(01):12\u201317. doi:10.1055/s-0028-1088333", "ArticleIdList": ["10.1055/s-0028-1088333", "19006050"]}, {"Citation": "Yang Y, Li J, Wei C, et al. Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice. Phytomedicine. 2019;59:152782. doi:10.1016/j.phymed.2018.12.005", "ArticleIdList": ["10.1016/j.phymed.2018.12.005", "31005808"]}, {"Citation": "Zhang Q, Chen K, Wu T, et al. Swertiamarin ameliorates carbon tetrachloride-induced hepatic apoptosis via blocking the PI3K/Akt pathway in rats. Korean J Physiol Pharmacol. 2019;23(1):21\u201328. doi:10.4196/kjpp.2019.23.1.21", "ArticleIdList": ["10.4196/kjpp.2019.23.1.21", "PMC6315090", "30627006"]}, {"Citation": "Wu T, Li J, Li Y, et al. Antioxidant and hepatoprotective effect of swertiamarin on carbon tetrachloride-induced hepatotoxicity via the Nrf2/HO-1 pathway. Cell Physiol Biochem. 2017;41(6):2242\u20132254. doi:10.1159/000475639", "ArticleIdList": ["10.1159/000475639", "28448964"]}, {"Citation": "Li S, Wang Q, Tao Y, et al. Swertiamarin attenuates experimental rat hepatic fibrosis by suppressing angiotensin II\u2013angiotensin type 1 receptor\u2013extracellular signal-regulated kinase signaling. J Pharmacol Exp Ther. 2016;359(2):247\u2013255. doi:10.1124/jpet.116.234179", "ArticleIdList": ["10.1124/jpet.116.234179", "27543328"]}, {"Citation": "Phoboo S, Pinto MDS, Barbosa ACL, et al. Phenolic\u2010linked biochemical rationale for the antidiabetic properties of Swertia chirayita (Roxb. ex Flem.) Karst. Phytother Res. 2013;27(2):227\u2013235. doi:10.1002/ptr.4714", "ArticleIdList": ["10.1002/ptr.4714", "22523004"]}, {"Citation": "Wani BA, Ramamoorthy D, Rather MA, et al. Induction of apoptosis in human pancreatic MiaPaCa-2 cells through the loss of mitochondrial membrane potential (\u0394\u03a8m) by Gentiana kurroo root extract and LC-ESI-MS analysis of its principal constituents. Phytomedicine. 2013;20(8\u20139):723\u2013733. doi:10.1016/j.phymed.2013.01.011", "ArticleIdList": ["10.1016/j.phymed.2013.01.011", "23453831"]}, {"Citation": "Vaidya H, Goyal RK, Cheema SK. Antidiabetic activity of swertiamarin is due to an active metabolite, gentianine, that upregulates PPAR\u2010\u03b3 gene expression in 3T3\u2010L1 cells. Phytother Res. 2013;27(4):624\u2013627. doi:10.1002/ptr.4763", "ArticleIdList": ["10.1002/ptr.4763", "22718571"]}, {"Citation": "Vaidya H, Giri S, Jain M, et al. Decrease in serum matrix metalloproteinase-9 and matrix metalloproteinase-3 levels in Zucker fa/fa obese rats after treatment with swertiamarin. Exp Clin Cardiol. 2012;17(1):12.", "ArticleIdList": ["PMC3383361", "23204894"]}, {"Citation": "Vaidya H, Prajapati A, Rajani M, et al. Beneficial effects of swertiamarin on dyslipidaemia in streptozotocin\u2010induced type 2 diabetic rats. Phytother Res. 2012;26(8):1259\u20131261. doi:10.1002/ptr.3708", "ArticleIdList": ["10.1002/ptr.3708", "22228612"]}, {"Citation": "Dhanavathy G. Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced \u03b2-cell damage in Wistar rat pancreas. J Endocrinol Investig. 2015;38(6):669\u2013684. doi:10.1007/s40618-015-0243-5", "ArticleIdList": ["10.1007/s40618-015-0243-5", "25770453"]}, {"Citation": "Patel TP, Soni S, Parikh P, et al. Swertiamarin: an active lead from Enicostemma littorale regulates hepatic and adipose tissue gene expression by targeting PPAR-\u03b3 and improves insulin sensitivity in experimental NIDDM rat model. J Evid Based Complementary Altern Med. 2013;2013.", "ArticleIdList": ["PMC3690633", "23840254"]}, {"Citation": "Sonawane RD, Vishwakarma SL, Lakshmi S, et al. Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in rats. Mol Cell Biochem. 2010;340(1\u20132):1\u20136. doi:10.1007/s11010-010-0393-x", "ArticleIdList": ["10.1007/s11010-010-0393-x", "20229291"]}, {"Citation": "Ahamad J, Hassan N, Amin S, et al. Swertiamarin contributes to glucose homeostasis via inhibition of carbohydrate metabolizing enzymes. J Nat Med. 2016;4:125\u2013130."}, {"Citation": "Patel TP, Rawal K, Soni S, et al. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis. Biomed Pharmacother. 2016;83:785\u2013791. doi:10.1016/j.biopha.2016.07.028", "ArticleIdList": ["10.1016/j.biopha.2016.07.028", "27490779"]}, {"Citation": "Kimura Y, Sumiyoshi M. Effects of Swertia japonica extract and its main compound swertiamarin on gastric emptying and gastrointestinal motility in mice. Fitoterapia. 2011;82(6):827\u2013833. doi:10.1016/j.fitote.2011.04.008", "ArticleIdList": ["10.1016/j.fitote.2011.04.008", "21571047"]}, {"Citation": "Yao L-S, Tang L-N, Liu C-Q, et al. Study on protective effect and possible mechanisms of swertiamarin against sepsis-induced acute lung injury in rats. Int J Clin Exp Med. 2016;9(7):13445\u201313455."}, {"Citation": "Pandey T, Smita SS, Mishra A, et al. Swertiamarin, a secoiridoid glycoside modulates nAChR and AChE activity. Exp Geront. 2020;138:111010. doi:10.1016/j.exger.2020.111010", "ArticleIdList": ["10.1016/j.exger.2020.111010", "32590127"]}, {"Citation": "Deng X-H, Zhang X, Wang J, et al. Anticonvulsant effect of swertiamarin against Pilocarpine-induced seizures in adult male mice. Neurochem Res. 2017;42(11):3103\u20133113. doi:10.1007/s11064-017-2347-0", "ArticleIdList": ["10.1007/s11064-017-2347-0", "28681096"]}, {"Citation": "Devinsky O, Vezzani A, Najjar S, et al. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013;36(3):174\u2013184. doi:10.1016/j.tins.2012.11.008", "ArticleIdList": ["10.1016/j.tins.2012.11.008", "23298414"]}, {"Citation": "Vezzani A, Baram TZ. New roles for interleukin-1 Beta in the mechanisms of epilepsy. Epilepsy Curr. 2007;7(2):45\u201350. doi:10.1111/j.1535-7511.2007.00165.x", "ArticleIdList": ["10.1111/j.1535-7511.2007.00165.x", "PMC1867084", "17505552"]}, {"Citation": "Uludag IF, Duksal T, Tiftikcioglu BI, et al. IL-1\u03b2, IL-6 and IL1Ra levels in temporal lobe epilepsy. Seizure. 2015;26:22\u201325. doi:10.1016/j.seizure.2015.01.009", "ArticleIdList": ["10.1016/j.seizure.2015.01.009", "25799897"]}, {"Citation": "Vezzani A, Aronica E, Mazarati A, et al. Epilepsy and brain inflammation. Exp Neurol. 2013;244:11\u201321. doi:10.1016/j.expneurol.2011.09.033", "ArticleIdList": ["10.1016/j.expneurol.2011.09.033", "21985866"]}, {"Citation": "Alsharafi WA, Xiao B, Abuhamed MM, et al. Correlation between IL-10 and microRNA-187 expression in epileptic rat hippocampus and patients with temporal lobe epilepsy. Front Cell Neurosci. 2015;9:466. doi:10.3389/fncel.2015.00466", "ArticleIdList": ["10.3389/fncel.2015.00466", "PMC4667084", "26696826"]}, {"Citation": "Vaijanathappa J, Puttaswamygowda J, Bevanhalli R, et al. Molecular docking, antiproliferative and anticonvulsant activities of swertiamarin isolated from Enicostemma axillare. Bioorg Chem. 2020;94:103428. doi:10.1016/j.bioorg.2019.103428", "ArticleIdList": ["10.1016/j.bioorg.2019.103428", "31740047"]}, {"Citation": "Wang H, Wei W, Lan X, et al. Neuroprotective effect of swertiamain on cerebral ischemia/reperfusion injury by inducing the Nrf2 protective pathway. ACS Chem Neurosci. 2019;10(5):2276\u20132286. doi:10.1021/acschemneuro.8b00605", "ArticleIdList": ["10.1021/acschemneuro.8b00605", "30753053"]}, {"Citation": "Tang H, Ke Y, Ren Z, et al. Bioinformatics analysis of differentially expressed genes in hepatocellular carcinoma cells exposed to Swertiamarin. J Cancer. 2019;10(26):6526. doi:10.7150/jca.33666", "ArticleIdList": ["10.7150/jca.33666", "PMC6856900", "31777582"]}, {"Citation": "Dubey S, Kallubai M, Subramanyam R. Comparative binding of swertiamarin with human serum albumin and \u03b1-1 glycoprotein and its cytotoxicity against neuroblastoma cells. J Biomol Struct Dyn. 2019;1\u201311.", "ArticleIdList": ["31755370"]}, {"Citation": "\u0160iler B, Mi\u0161i\u0107 D, Nestorovi\u0107 J, et al. Antibacterial and antifungal screening of Centaurium pulchellum crude extracts and main secoiridoid compounds. Nat Prod Commun. 2010;5(10):1934578X1000501001.", "ArticleIdList": ["21121240"]}, {"Citation": "Dhanavathy G, Jayakumar S. Acute and subchronic toxicity studies of Swertiamarin a lead compound isolated from Enicostemma littorale Blume in wistar rats. Biosci Biotech Res Asia. 2017;14(1):381\u2013390. doi:10.13005/bbra/2456", "ArticleIdList": ["10.13005/bbra/2456"]}, {"Citation": "Shi M, Xiong K, Zhang T, et al. Pharmacokinetics and metabolic profiles of swertiamarin in rats by liquid chromatography combined with electrospray ionization tandem mass spectrometry. J Pharm Biomed. 2020;179:112997. doi:10.1016/j.jpba.2019.112997", "ArticleIdList": ["10.1016/j.jpba.2019.112997", "31767226"]}, {"Citation": "Li H-L, He J-C, Bai M, et al. Determination of the plasma pharmacokinetic and tissue distributions of swertiamarin in rats by liquid chromatography with tandem mass spectrometry. Drug Res. 2012;62(03):138\u2013144.", "ArticleIdList": ["22278630"]}, {"Citation": "Xu G-L, Li H-L, He J-C, et al. Comparative pharmacokinetics of swertiamarin in rats after oral administration of swertiamarin alone, Qing Ye Dan tablets and co-administration of swertiamarin and oleanolic acid. J Ethnopharmacol. 2013;149(1):49\u201354. doi:10.1016/j.jep.2013.05.016", "ArticleIdList": ["10.1016/j.jep.2013.05.016", "23791808"]}, {"Citation": "Bezivin C. Cosmetic uses of swertiamarin. Google Patents. 2017."}, {"Citation": "Muhamad Ibrahim A, Nagarajan A, Majeed M. Swertiamarin ointment: a traditional approach in cutaneous wound healing. Asian J Pharm Pharmacol. 2019;5(2):298\u2013309. doi:10.31024/ajpp.2019.5.2.13", "ArticleIdList": ["10.31024/ajpp.2019.5.2.13"]}, {"Citation": "Kumar S, Niguram P, Bhat V, et al. Synthesis, molecular docking and ADMET prediction of novel swertiamarin analogues for the restoration of type-2 diabetes: an enzyme inhibition assay. Nat Prod Res. 2020;1\u201311.", "ArticleIdList": ["32998578"]}, {"Citation": "Bhatt J, Vaidya H, Khanna V, et al. In silico docking studies for designing potent anti-diabetic derivatives of swertiamarin with enzyme HMG COA reductase. Mol Cytogenet. 2014;7(1):1. doi:10.1186/1755-8166-7-S1-P97", "ArticleIdList": ["10.1186/1755-8166-7-S1-P97", "0"]}, {"Citation": "Zhang M-Q, Wilkinson B. Drug discovery beyond the \u2018rule-of-five\u2019. Curr Opin Biotechnol. 2007;18(6):478\u2013488. doi:10.1016/j.copbio.2007.10.005", "ArticleIdList": ["10.1016/j.copbio.2007.10.005", "18035532"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "31"}, {"Year": "2021", "Month": "2", "Day": "4"}, {"Year": "2021", "Month": "6", "Day": "30", "Hour": "6", "Minute": "34"}, {"Year": "2021", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["34188450", "PMC8233004", "10.2147/DDDT.S299753", "299753"]}}], "PubmedBookArticle": []}